|
|
|
|
|
|
|
|
|
|
St. Nicholas Home
> Global News Update
Global News Update
Metabolex Announces Positive Results From Phase 2 Clinical Trial Of MBX-8025
Metabolex, Inc., a biopharmaceutical company focused on the discovery and development of proprietary new medicines for the treatment of metabolic diseases, announced positive results from a Phase 2 clinical trial of MBX-8025. A summary of the results was presented at the World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy) on November 1, 2008. MBX-8025 is an oral drug candidate that is being evaluated for the treatment of dyslipidemia.
http://www.medicalnewstoday.com/articles/129872.php
Soy Protein's Ability To Lower Cholesterol Confirmed, Possible Mechanism Of Action Described
Solae, a leader in soy protein innovation and technology, unveiled a new study today at the 8th International Symposium on the Role of Soy in Health Promotion and Chronic Disease Prevention and Treatment. A new meta-analysis confirms that soy protein consumption can lead to a meaningful and significant reduction in blood cholesterol levels.
http://www.medicalnewstoday.com/articles/129662.php
Colesevelam HCl Lowered LDL Cholesterol In Pediatric Patients With Heterozygous Familial Hypercholesterolemia
Daiichi Sankyo, Inc. (DSI), announced today that results from the pivotal study supporting the use of colesevelam HCl in pediatric patients with heterozygous familial hypercholesterolemia (heFH), were presented for the first time at the American Heart Association's (AHA) Annual Scientific Sessions 2008.
http://www.medicalnewstoday.com/articles/129654.php
New Berry On The Block Packs Twice The Antioxidants
The Little-Known Black Elderberry Is "Berry" Good For Your Health; Clinically-Proven To Support Immune Function (PRWeb Nov 19, 2008) Read the full story at http://www.prweb.com/releases/2008/11/prweb1635374.htm
http://www.prweb.com/releases/2008/11/prweb1635374.htm
Epocrates Survey Identifies Trends in Online Resource Use Among Physicians
Internet access becomes an increasingly important part of patient consultations. (PRWeb Nov 18, 2008) Read the full story at http://www.prweb.com/releases/2008/11/prweb1607974.htm
http://www.prweb.com/releases/2008/11/prweb1607974.htm
Pilot Study Finds Adding Topical Imiquimod To Laser Therapy Improves The Response Of Port Wine Stain Birthmarks
Two-thirds of all port wine stain birthmarks occur on the face. As such, there is a strong need for an effective, long-lasting treatment that safely fades these reddish-purple skin lesions that can have a huge impact on a patient's physical and emotional well-being. Now, a new study evaluating the combined use of pulsed dye laser (PDL) therapy and topical Imiquimod to treat port wine stain birthmarks shows promising results. (PRWeb Nov 18, 2008) Read the full story at http://www.prweb.com/releases/2008/11/prweb1615394.htm
http://www.prweb.com/releases/2008/11/prweb1615394.htm
Pancreatic Insufficiency - Altus Pharmaceuticals Plans To Submit New Drug Application For Trizytek Approval
Altus Pharmaceuticals Inc. (NASDAQ: ALTU) announced today that it is reaffirming its plan to submit a new drug application (NDA) for Trizytek TM (liprotamase) in the first-half of 2009. Trizytek is a non-porcine derived enzyme replacement therapy for patients with pancreatic insufficiency.
http://www.medicalnewstoday.com/articles/129894.php
Major Breakthrough Transforms Field Of Hormone Receptor Research
For decades, scientists have been studying nuclear hormone receptors to gain a better understanding of how they turn genes on and off throughout the body and how they function as key drug targets for a number of diseases, such as diabetes, breast cancer, osteoporosis and high cholesterol. A new UVA Health System study, led by Fraydoon Rastinejad, Ph.D.
http://www.medicalnewstoday.com/articles/129710.php
Intravail(R) Drug Delivery Technology Provides Unmatched Non-Invasive Delivery Of An Anti-Obesity Peptide
Aegis Therapeutics LLC announced today that preclinical data was presented at the 2008 International Congress of Endocrinology in Rio de Janeiro, Brasil demonstrating that its Intravail(R) formulation technology provides unmatched non-invasive delivery of the OB-3 peptide, a peptide previously shown to control weight gain and glucose levels in an animal model of diabetes. The results of the study, presented by Dr.
http://www.medicalnewstoday.com/articles/129647.php
Mothers See Flu As Serious Health Threat, But Often Don't Get Their Families Vaccinated
While 78 percent of mothers in the United States consider influenza a severe and potentially life-threatening disease that can strike anyone, only half say it is likely their families will get vaccinated this season, according to a new survey from the American Lung Association.
http://www.medicalnewstoday.com/articles/129974.php
It's Not Too Late; Get Your Flu Shot Now
The Alabama Department of Public Health encourages the public to get their flu shots. Contact your local health care provider or county health department to ask about influenza vaccination. "An ample supply of influenza vaccine remains available this season," said Dr. Donald Williamson, state health officer. "Influenza usually peaks during the months of January and February in Alabama, so it's not too late to be immunized.
http://www.medicalnewstoday.com/articles/129831.php
Cold/Flu Breakthrough Remedy Undergoes NCI-Sponsored Trial In Leukemia Patients: Canada
Cancer patients - with their weakened immune systems - are particularly vulnerable when the cold and flu season hits. To help, the U.S. National Cancer Institute (NCI) is sponsoring a landmark trial to see whether a unique Canadian cold remedy - COLD-FX - can help.
http://www.medicalnewstoday.com/articles/129834.php
New U.S. Army Mosquito Control Technology Licensed For Deployment Against Dengue
A novel, patented mosquito-killing technology developed by U.S. Army researchers under a long-term, joint-development agreement between the Walter Reed Army Institute of Research , the United States Army Medical Research and Materiel Command, and the U.S.
http://www.medicalnewstoday.com/articles/130061.php
Critical Gap In Global Health Covered By Primate Disease Field Guide
Why are so many infectious diseases jumping from animals to humans? Why do we have so little capacity to predict epidemics, or avoid them? Some answers, and possible solutions, can be found in the first trench-to-bench guide to wild primate infectious diseases, published Nov. 17 in the Yearbook of Physical Anthropology. "There is growing awareness that the majority of emerging pathogens in the world are coming from wildlife.
http://www.medicalnewstoday.com/articles/130025.php
Gates Foundation Awards Grant For Development Of A Database To Accelerate Discovery Of New Therapies Against Tuberculosis
Collaborative Drug Discovery, Inc. (CDD) today announced that it has received a grant for $1,896,923 from the Bill & Melinda Gates Foundation to develop a collaborative database that will enable scientists to archive, mine, and selectively collaborate around their research data to discover new cures for tuberculosis (TB). The TB bacillus infects approximately one third of the world's population and the disease kills over 1.5 million people every year.
http://www.medicalnewstoday.com/articles/129997.php
New Certification In Medical Publications Planning Reinforces Professional Credibility And Integrity
The International Society for Medical Publication Professionals (ISMPP) is implementing a certification program that will, for the first time ever, offer professionals an opportunity to earn the newly established Certified Medical Publication Professional (CMPP) credential. Publication planning is a relatively new profession with few defined common standards and established "best practices.
http://www.medicalnewstoday.com/articles/130050.php
New Ph.D. Path Linking Laboratory And Population Sciences Created By Burroughs Wellcome Fund Award
The Burroughs Wellcome Fund (BWF) has selected Emory University for a $2.5 million, five-year award aimed at training new biomedical scientists whose expertise in research and teaching will bridge laboratory and population sciences. The Emory program is one of three new BWF programs funded nationally within the Institutional Program Unifying Population and Laboratory Based Sciences.
http://www.medicalnewstoday.com/articles/130027.php
International Health Research Gets Boost With NIH Grant To Create Bioethics Master's Degrees At Indiana And Moi Universities, USA
A new partnership between the Indiana University and Kenya's Moi University will develop master's degrees at both universities that focus on ethical issues in international health research. The program, funded with a $940,000 award from the National Institutes of Health Fogarty International Center, will create the Indiana University-Moi University Academic Research Ethics Partnership (IU-Moi AREP).
http://www.medicalnewstoday.com/articles/129998.php
|
|
|
|
|
|
|
|
|
